logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


5 Micro and Small-Cap Biotechs Developing Stem Cell Treatments

By  +Follow August 1, 2013 8:43AM
Share:
Tickers Mentioned:

Stem cells have once again flitted through the news cycle, this time as a result of a new and growing industry that has arisen around the use of adult stem cells in cosmetic treatments that purport to both be more effective and less dangerous than traditional procedures such as the infamous and potentially toxic Botox injections.

But the scientific basis for the use of stem cells for cosmetic procedures is entirely tentative. To date, the US Food and Drug Administration has not approved any stem cell-based products for use, aside from a small number of umbilical cord blood-derived treatments for blood cancer as well as hereditary metabolic and autoimmune disorders.

Cosmetic treatments of any variety are subject to far less scrutiny than medical treatments, however, and this is what is currently allowing an increasing amount of doctors throughout the country to charge as much as $30,000 for procedures whose value are more or less unproven from the standpoint of official studies, clinical trials, and peer reviews.

Considering that so few medical products involving stem cells have been approved, a high degree of skepticism should probably be applied to any magical claims about the potential for stem cells to make one look younger, or to otherwise repair one’s perceived cosmetic iniquities. A terrifying article that appeared last December in The Scientific American suffices to support this contention.

But stem cells, whether of the adult of cord-blood variety, are believed to have regenerative properties that could repair all manner of human diseases and conditions, from cardiovascular conditions, to autoimmune diseases. The following five companies are biotechs that are working to ostensibly better the human condition through the use of stem-cell technology, and are all in the midst of clinical trials for various treatments, or on their way to beginning them

Osiris Therapeutics (OSIR) — With a market cap of $377 million, the Columbia, Maryland-based Osiris Therapeutics focuses on the development and marketing of stem cell products to treat serious inflammatory, autoimmune, orthopedic, and cardiovascular conditions. The company’s shares are currently priced at $11.45 and are up over 38 percent over the last six months.

Pluristem (PSTI) — The Israel-based Pluristem develops stem cell therapies from placenta cells for a number of diseases, and is currently preparing for clinical trials for a Peripheral Artery Disease treatment. The company has a market cap of $173.9 million, with shares trading at $2.98, down 7 percent over the past half year.

Cytori Therapeutics (CYTX) — Cytoris Therapeutics uses adult stem cells to develop regenerative therapies for cardiovascular conditions and soft tissue defects. The US company has a market cap of $188.9 million with shares currently priced at $2.82, up 2.5 percent over the last six months.

Neostem (NBS) — The New York, NY-based Neostem owns and operates a number of subsidiaries in the stem-cell based regenerative medicine industry that develop treatments for cardiovascular, autoimmune, and inflammatory conditions. The company is nearing clinical trials for a periodontitis treatment. With a market cap of $117.7 million, shares are currently priced at $7.05, up 10 percent over the past six months, and 17 percent year-to-date.

Advanced Cell Technology ($ACTC) — The Santa Monica, CA-based Advanced Cell Technology uses both adult and embryonic stem cells to develop treatments for retinal, blood, and heart diseases, and has recently initiated two different clinical trials for degenerative retinal disease. With a market cap of $179 million, shares are currently priced at $0.07, down $0.01 over the past six months.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for cytx
Ace
3 Sep 15 04:45:18
Premarket Top % Gainers: $GERN 18%, $ACAD 10%, $CYTX 10%, $GEVO 7%, $LABU 5%, $NAVB 4%, $FMS 4%, $DUST 3%, $SUNE 3%, $ASML $TSLA $ARMH $FRO
Rusty the Stock Guy
3 Sep 15 04:44:01
$cytx nice news this morning http://t.co/GsbauFuzgx
ProbabilityOne
3 Sep 15 04:43:44
RT @ACInvestorBlog: Long setups for Thursday http://t.co/uFczaDZ3Xl other stocks to watch $CIEN $YGE $FTR $CYTX $ACAD $SYMC $PYPL $TWTR $NF…
MacroMeal
3 Sep 15 04:39:13
$CYTX we got news! Letsssss gooooooo!!!!
Adelitas Photography
3 Sep 15 04:33:44
US Stock Futures Gain Ahead Of Jobless Claims $ARMH $CYTX $HAL via @benzinga http://t.co/BY4RD4KtSy
Antonio Costa
3 Sep 15 04:30:48
Long setups for Thursday http://t.co/uFczaDZ3Xl other stocks to watch $CIEN $YGE $FTR $CYTX $ACAD $SYMC $PYPL $TWTR $NFLX $GERN $EBAY $SUNE
svenmhartke
3 Sep 15 04:28:22
$CYTX Enrollment Begins in Cytori Phase III/Pivotal ADRESU Urinary Incontinence Trial http://t.co/2YM09NYcIP
Bats
3 Sep 15 04:22:40
$GERN $CYTX
Chill Till
3 Sep 15 04:14:12
$CYTX Cytori Therapeutics begins enrollment in Phase III Adresu trial. http://t.co/1sqlCSFBXZ
Pzaa...Guy
3 Sep 15 04:01:13
$CYTX - Enrollment Begins in Cytori Phase III/Pivotal ADRESU Urinary Incontinence Trial http://t.co/TxedT6dupE
StockNews
3 Sep 15 04:01:10
$CYTX - Enrollment Begins in Cytori Phase III/Pivotal ADRESU Urinary Incontinence Trial http://t.co/WAzCtO5gNN
$Stocknewsalerts
3 Sep 15 04:00:36
$CYTX Cytori - Enrollment Begins in Cytori Phase III/Pivotal ADRESU Urinary Incontinence Trial From our Stock News Alerts App
Ace
3 Sep 15 03:51:19
Premarket Top % Gainers: $GERN 30%, $CYTX 27%, $FMS 4%, $ASML 3%, $TSLA 3%, $SVXY 2%, $ICL $XIV $ARMH $UGAZ $ERIC $HAL $AZN $NVO $SWKS $UWTI
Pzaa...Guy
3 Sep 15 03:15:11
$CYTX - Statement of Changes in Beneficial Ownership (4) http://t.co/V76CXV4Hx9
StockNews
3 Sep 15 03:15:09
$CYTX - Statement of Changes in Beneficial Ownership (4) http://t.co/hJZKaStwej
ProVesting
3 Sep 15 03:10:02
$CYTX: New Insider Transaction on CYTX by General Counsel & VP of BD: http://t.co/L9xQpg3EEL
Insider Alerts
3 Sep 15 03:09:18
NEW insider transaction on $CYTX reported a moment ago: http://t.co/QxqC1QhtQn
$Stocknewsalerts
3 Sep 15 03:07:39
$CYTX Cytori - 4 (Statement of Changes in Beneficial Ownership) SEC Filing From our Stock News Alerts App
Insider Filings
3 Sep 15 03:06:23
$CYTX: HAYDEN JEREMY B. bought a net $2,911 in CYTORI THERAPEUTICS, INC.. http://t.co/svZa5xxZPA
Nara
2 Sep 15 21:21:30
$ERB $HART $BLPH $CFMS $IGC $CYTX JBEM New Pick Release after TRVN. Details here: https://t.co/gv9He7HRvh
Kristina Duering
2 Sep 15 16:02:24
RT @Lin_ling_88: Biotech Stocks: Here’s Where to Get In- $CYTX $TRVN $PBMD http://t.co/8TpfAsDgiJ
Helen Ong
2 Sep 15 15:13:12
Biotech Stocks: Here’s Where to Get In- $CYTX $TRVN $PBMD http://t.co/8TpfAsDgiJ
MacroMeal
2 Sep 15 11:06:35
$CYTX boring hoping for some end of the day volume....
Nara
2 Sep 15 10:49:38
$MFRI $LFVN $MGN $CUBN $CYTX $LITB JBEM Glioblastoma Data Trade. Read full DD here: https://t.co/gv9He7HRvh
TimeForGrowth
2 Sep 15 09:24:02
$CYTX: Wall Street analysts bullish on CYTX's earnings growth: http://t.co/FmX38jzFtF http://t.co/Hfi0HRuXdp
Dave
2 Sep 15 08:51:28
http://t.co/L46QQZtU0M IN PLAY: $CYTX $CUZ $FMSA $NR $SMFG $OOIL $SNTA $ARWR $GLNCY $MBT $MDWCQ $OFG $RSHCQ http://t.co/DUwLY1dq9k
Dave
2 Sep 15 08:51:09
http://t.co/L46QQZciCc IN PLAY: $CYTX $CUZ $FMSA $NR $SMFG $OOIL $SNTA $ARWR $GLNCY $MBT $MDWCQ $OFG $RSHCQ http://t.co/2QdYPbvnr0
Dave
2 Sep 15 08:48:20
http://t.co/L46QQZciCc IN PLAY: $CYTX $CUZ $FMSA $NR $SMFG $OOIL $SNTA $ARWR $GLNCY $MBT $MDWCQ $OFG $RSHCQ http://t.co/Te65gleS1h
Todd
2 Sep 15 08:34:27
$CYTX relax, nothing goes up forever or down forever... This will rebound
MacroMeal
2 Sep 15 08:22:38
$CYTX buyin in on the dip,
ProTradersNews
2 Sep 15 06:16:03
$TRVN $PBMD $CYTX: Biotech Stocks: Here’s Where to Get In- Trevena Inc (NASDAQ …: http://t.co/043UiWL5Rw
Jabookie
2 Sep 15 04:34:23
@BakuExchange yep. On to the next. I took $CYTX. Bouncing off bottom and good volume of late. Congrats bud!
7 fits
2 Sep 15 00:07:06
RT @Cytori: Investor Note: First Patient Treated in the U.S. STAR Trial for #Scerloderma $CYTX http://t.co/tbRTLS0Fng
Linda Bell
1 Sep 15 23:13:11
Biotech Stocks to Love: $OPK $CYTX $ARNA http://t.co/h0RKVaWKtC
Russell Barbour
1 Sep 15 16:39:39
http://t.co/zkwrjD3miQ <<-- SuperTrades another huge win - check out his service its amazing!! $BIOC $CRM $PTCT $CYTX $CYCC
MacroMeal
1 Sep 15 13:18:41
$CYTX good job. Straight profits.
Brent Armstrong
1 Sep 15 11:34:35
$CYTX seems to me like the bottom was in at high .20's slow move up now till news https://t.co/ksA9q7omaO
JC
1 Sep 15 10:13:31
Holding off on $UWTI for the time being. http://t.co/rAXkMJ3TOn. $CYTX is still hanging in there..
brian sweetheart
1 Sep 15 09:14:16
Voted top trading group. http://t.co/5eVXN8RJLp Related: $ARR $FCEL $MARA $CYTX $CTIC $BAA $YGE
Stoxline Investing
1 Sep 15 08:49:03
$CYTX Technicals are showing great signs of upside potential. Six months target: $0.47 http://t.co/iGlWyJ6KKb
Daily Contracts
1 Sep 15 08:25:05
Real-Time feed of company contracts, original agreements and executive updates from $CYTX http://t.co/gqwpW5tHRQ
Melissa
1 Sep 15 08:19:08
All my big cap biopharmas are screaming at me today 😓...at least the little ones are okay $PBMD $OPXA $TRVN $CYTX
MacroMeal
1 Sep 15 08:16:44
$CYTX once china makes some gains then the dow will make gains then…..WE WILL MAKE GAINS!! http://t.co/RsFCHj0Pmm
StockNewsWires
1 Sep 15 06:52:02
$CYTX $MBI: • The Best Stocks to Watch: Cytori Therapeutics Inc (NASDAQ:CYTX …: http://t.co/GoiYniKdNF
Consumer News
1 Sep 15 06:05:56
Cytori Therapeutics Director David Rickey Acquires 56,000 Shares $CYTX http://t.co/TO43vbll3g #acn
Breaking News Now
1 Sep 15 03:52:03
$CYTX: Insider Buys Are Telling Something: Kroger Co (NYSE:KR), Apache …: http://t.co/mKPhnCVK8A
Breaking News
1 Sep 15 03:52:03
$CYTX: Biotech Stocks Attracting Some Extra Attention – Cytori Therapeutics …: http://t.co/szL7yZy6Dk
TimeForGrowth
31 Aug 15 23:32:02
$CYTX: Wall Street analysts bullish on CYTX's earnings growth: http://t.co/FmX38jzFtF http://t.co/apqSCLRfiq
Reed Skinner
31 Aug 15 18:10:14
$CYTX Would love this to fly tomorrow! Been long for months!
StockNewsWires
31 Aug 15 17:27:03
$CYTX: A Director at Cytori Therapeutics Inc (NASDAQ: CYTX) is Buying …: http://t.co/0wu86kbnui
				
				
By  +Follow August 1, 2013 8:43AM
Share:

Comments

 

blog comments powered by Disqus

 Today's Must Reads

Welcome to Equities.com's Small-Cap Throwdown


These Analysts Called Apple's (AAPL) Collapse, Here's What They're Saying Now

7 Dow Stocks Worth Owning and a Lot that Aren't

Sprint Turnaround Has Begun


Saving the

Small-Cap Market

 

Small-cap stocks offer investors many benefits, ranging from higher growth potential to overlooked value opportuni... in Equities.com's Hangs on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register

LOG IN